Luncheon Seminar 2 part 1

[LS2-1-01] The role of darolutamide in progressive prostate cancer: ~from M0CRPC to mHSPC~

*Kazuhiro Suzuki¹ (1. Department of Urology, Gunma University Graduate School of Medicine)

[Biography]
Dr. Suzuki is professor and chair of the Department of Urology, Gunma University Graduate School of Medicine and professor Heavy Ion Medical Center, Gunma University. His clinical interests include biology, screening and treatment of prostate cancer. He is involved in committee of JUA guidelines of prostate cancer and screening of prostate cancer. He is a member of JUA, JSCO, JSMO, AUA, ASCO, ESMO and several academic meetings. He is also involved in the Japanese Foundation for Prostate Research. In ARAMIS study, he was a PI in a Japan section.